Michael Georgetson, MD

Care Provider Overall: 
Patient Ratings: 
  • Clinical Details
  • Education
  • News & Video
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Corning Hospital
  • Guthrie Robert Packer Hospital
  • Guthrie Troy Community Hospital
Clinical Interests: 
  • Dysphagia
  • ERCP
  • Esophageal Diseases
  • Gastrointestinal Bleeding
  • Gastrointestional Neoplasia

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of Recommending Care Provider: 
Patients' Confidence in Care Provider: 
Time Care Provider Spent with Patient: 
Care Provider Spoke Using Clear Language: 
Care Provider Efforts to Include in Decisions: 
Care Provider's Concern for Questions and Worries: 
Care Provider's Explanations of Condition/Problem: 
Care Provider Information About Medications: 
Care Provider Instructions for Follow-Up Care: 
Care Provider's Friendliness and Courtesy: 
  • Robert Packer Hospital, Sayre, Pa.
  • American Board of IM/Gastroenterology
  • Jefferson Medical College, Philadelphia, Pa.
  • Robert Packer Hospital, Sayre, Pa.
  • Fellow of the American College of Gastroenterology (FACG)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Georgetson MD, FACG, Michael
Sponsor: MedImm
Details (Identifier #): NCT02574637
Title: DC5170C00002, A Phase 2b Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects with Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson MD, FACG, Michael
Sponsor: Janssen
Details (Identifier #): NCT02407236
Title: CNTO1275UCO3001, A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Georgetson MD, FACG, Michael
Sponsor: Salix
Details (Identifier #): NCT02240121
Title: A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional Study to Assess the Efficacy and Safety of Rifaximin Delayed Release Tablets for the Induction and Maintenance of Remission in Subjects with Active Moderate Crohn's Disease (RECD3125)

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Guthrie Patient: December 2016
Dr. Georgetson is the finest ganstroeneterologist one could possibly want working on you. This time was no different as we received nothing less than the finest most professional care one could ask for.
Guthrie Patient: November 2016
The care providers are excellent, it is the time restrictions and what seems like 'overbooking' that is the problem. I may be over evaluating all of this since I am seen at Mayo Clinic 2 or more times a year. Guthrie should not compare their services to Mayo.
Guthrie Patient: November 2016
The compassion and care of the provider was outstanding.
Guthrie Patient: November 2016
Very satisfied.
Guthrie Patient: October 2016
the dr was very good at explaining things to me when he seen that I was confused he started all over again. Very nice and pleasant Dr.